Koers IR Biosciences Holdings Inc. Other OTC
Aandelen
IRBS
US46264M3034
Biotechnologie & Medisch Onderzoek
Omzet 2009 | - | Omzet 2010 | - | Marktkapitalisatie | 1,2 mln. 1,12 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | -6 mln. -5,62 mln. | Nettowinst (verlies) 2010 | -5 mln. -4,68 mln. | EV/omzet 2009 | - |
Nettoschuld 2009 | 5,81 mln. 5,44 mln. | Nettoschuld 2010 | 3,67 mln. 3,44 mln. | EV/omzet 2010 | - |
K/w-verhouding 2009 |
-0,37
x | K/w-verhouding 2010 |
-0,2
x | Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-07-03 | |
John N. Fermanis
DFI | Director of Finance/CFO | 70 | 01-12-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-07-03 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+30,50% | 52,73 mld. | |
+37,55% | 39 mld. | |
-9,56% | 38,52 mld. | |
+26,28% | 30,38 mld. | |
-11,17% | 26,39 mld. | |
+9,96% | 26,08 mld. | |
+44,55% | 14,15 mld. | |
+32,91% | 12,6 mld. | |
-5,83% | 11,51 mld. |